Invexans S.A. reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was USD 1,487.29 million compared to USD 1,162.09 million a year ago. Net income was USD 15.87 million compared to USD 26.16 million a year ago.

Basic earnings per share from continuing operations was USD 0.0003 compared to USD 0.0005 a year ago. Diluted earnings per share from continuing operations was USD 0.0003 compared to USD 0.0005 a year ago.